Published in J Nephrol on September 20, 2010
Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care (2013) 1.20
Section 5: Dialysis Interventions for Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.79
Sustained low-efficiency dialysis in septic shock: Hemodynamic tolerability and efficacy. Indian J Crit Care Med (2016) 0.78
Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations. BMC Pharmacol Toxicol (2013) 0.78
Dialysis complications in AKI patients treated with extended daily dialysis: is the duration of therapy important? Biomed Res Int (2014) 0.78
Extended daily dialysis in acute kidney injury patients: metabolic and fluid control and risk factors for death. PLoS One (2013) 0.77
Acute kidney injury in critically ill cancer patients: an update. Crit Care (2016) 0.75
Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients. Pharmacol Res Perspect (2016) 0.75
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol (2017) 0.75
A Pilot Randomized Controlled Trial of Comparison between Extended Daily Hemodialysis and Continuous Veno-venous Hemodialysis in Patients of Acute Kidney Injury with Septic Shock. Indian J Crit Care Med (2017) 0.75
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes (2006) 5.29
Pathogenesis and management of hypertension after kidney transplantation. J Hypertens (2011) 2.66
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2011) 2.27
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care (2008) 1.94
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant (2009) 1.86
Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 1.86
Hepatic gas gangrene following liver transplantation. Liver Transpl (2007) 1.85
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 1.79
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care (2010) 1.65
Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol (2007) 1.63
Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes. Metabolism (2012) 1.55
Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis (2004) 1.55
Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med (2009) 1.53
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med (2006) 1.51
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest (2011) 1.49
Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. Clin J Am Soc Nephrol (2012) 1.48
Deficits in sialylation impair podocyte maturation. J Am Soc Nephrol (2012) 1.47
ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis. Nephrol Dial Transplant (2010) 1.44
A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation. Transpl Int (2015) 1.39
Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant (2011) 1.36
Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol (2005) 1.33
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant (2012) 1.29
Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrol Dial Transplant (2010) 1.23
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21
Cofilin-1 inactivation leads to proteinuria--studies in zebrafish, mice and humans. PLoS One (2010) 1.20
Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant (2008) 1.19
Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol (2008) 1.18
PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Biol Chem (2011) 1.17
TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol (2009) 1.16
CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. J Biol Chem (2010) 1.13
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol (2009) 1.12
Scleroderma-like acute renal crisis in a patient with scleromyxedema. Nephrol Dial Transplant (2007) 1.07
Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol (2007) 1.07
B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant (2009) 1.06
Renal function and survival in 200 patients undergoing ECMO therapy. Nephrol Dial Transplant (2012) 1.04
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant (2008) 1.03
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol (2006) 1.03
Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study. Nephrol Dial Transplant (2009) 1.02
An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS One (2013) 1.01
Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS One (2010) 1.01
Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. Am J Physiol Renal Physiol (2007) 0.99
"Zebrafishing" for novel genes relevant to the glomerular filtration barrier. Biomed Res Int (2013) 0.98
The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant (2010) 0.98
PKC-alpha modulates TGF-beta signaling and impairs podocyte survival. Cell Physiol Biochem (2009) 0.96
Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif (2009) 0.95
Prometheus--a new extracorporeal system for the treatment of liver failure. J Hepatol (2003) 0.95
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin. BMC Nephrol (2010) 0.94
Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy. BMC Pharmacol Toxicol (2013) 0.94
CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem (2007) 0.93
IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol (2006) 0.93
Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol (2011) 0.88
The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab Res Rev (2011) 0.88
Renal involvement in preeclampsia: similarities to VEGF ablation therapy. J Pregnancy (2010) 0.88
Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol (2014) 0.87
New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysis. Blood Purif (2012) 0.86
The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif (2005) 0.85
aPKCλ/ι and aPKCζ contribute to podocyte differentiation and glomerular maturation. J Am Soc Nephrol (2013) 0.85
Removal of elevated circulating angiopoietin-2 by plasma exchange--a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease. Thromb Haemost (2010) 0.85
Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation. Cell Cycle (2008) 0.85
Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study. Transpl Int (2014) 0.85
Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients. J Transplant (2012) 0.84
Genomic strategies for diabetic nephropathy. J Am Soc Nephrol (2003) 0.84
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis. J Med Virol (2008) 0.84
Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol (2005) 0.84
Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults. Neurology (2012) 0.83
Knockdown of the hypertension-associated gene NOSTRIN alters glomerular barrier function in zebrafish (Danio rerio). Hypertension (2013) 0.83
Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis--a single case. Nephrol Dial Transplant (2009) 0.82
High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy? Ann Hematol (2013) 0.82
Failed rescue therapy with rapamycin after paraquat intoxication. Clin Toxicol (Phila) (2010) 0.81
CD2AP regulates SUMOylation of CIN85 in podocytes. Mol Cell Biol (2011) 0.81
Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen. Eur J Clin Invest (2014) 0.81
The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury. Int J Cell Biol (2011) 0.79
Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS. J Nephrol (2012) 0.79
Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease. Growth Factors (2010) 0.79
Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι. Am J Pathol (2013) 0.78
Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy. Am J Pathol (2011) 0.78
Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scand J Gastroenterol (2006) 0.78
Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children. Paediatr Drugs (2008) 0.77
TGF-β/BMP pathways and the podocyte. Semin Nephrol (2012) 0.77
Effect of isovolemic, isothermic hemodialysis on cerebral perfusion and vascular stiffness using contrast computed tomography and pulse wave velocity. PLoS One (2013) 0.76
Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival. Langenbecks Arch Surg (2014) 0.76
Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome. PLoS One (2012) 0.76
Cytomegalovirus peritonitis after renal transplantation under induction therapy with alemtuzumab in a young woman previously treated with peritoneal dialysis. Nephrol Dial Transplant (2005) 0.76
Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS). Thromb Haemost (2013) 0.76
Effect of acute kidney injury requiring extended dialysis on 28 day and 1 year survival of patients undergoing interventional lung assist membrane ventilator treatment. BMC Nephrol (2011) 0.75
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II. Ann Thorac Surg (2009) 0.75
Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption. Scand J Gastroenterol (2010) 0.75
Overexpression of TGF-β Inducible microRNA-143 in Zebrafish Leads to Impairment of the Glomerular Filtration Barrier by Targeting Proteoglycans. Cell Physiol Biochem (2016) 0.75
Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series. Nephrol Dial Transplant (2011) 0.75
Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis. Nephron Clin Pract (2014) 0.75